Top Industry Leaders in the Cell Therapy Market
Latest Cell Therapy Companies Update
Novartis receives FDA approval for Kymriah, a CAR-T cell therapy for acute lymphoblastic leukemia (ALL), marking a significant milestone in personalized cancer treatment. This approval reinforces the potential of CAR-T therapies for challenging diseases.
BlueRock Therapeutics raises $375 million in funding to advance its stem cell treatment for Parkinson's disease, highlighting the growing investor confidence in cell therapy for neurodegenerative conditions
Vertex Pharmaceuticals and CRISPR Therapeutics announce positive Phase 1/2 data for their investigational gene editing therapy for sickle cell disease, demonstrating the therapeutic potential of combining gene editing with cell therapy.
List of Cell Therapy Key Companies in the Market
- Kolon TissueGene Inc.
- AlloSource
- Holostem Terapie Avanzate S.R.L.
- AlloSource
- Holostem Terapie Avanzate S.R.L.
- Castle Creek Biosciences Inc.
- Anterogen Co. Ltd
- Celgene Corporation
- Tameika Cell Technologies Inc.